Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacokinetics and Pharmacodynamics of Oral and Vaporized THC in Older Adults
NCT05906511Phase 1Completed
- Sponsor
- Yale University
- Start
- Oct 2023
- Primary completion
- Apr 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of dronabinol in pain (5 arms), sponsored by Yale University. Primary endpoints: Peak concentration at 8 hours, Time to attain Cmax concentration at 8 hours and 3 more. Started Oct 2023; status: completed.
02
Drugs
dronabinol
03
Conditions
pain
Beyond the preview
Go deeper on NCT05906511.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05906511.